Since their approval in 2010, direct oral anticoagulants (DOACs) have become integral in treating and preventing thromboembolic diseases.
No takes yet. Share an insight, caveat, or question.
Mahajan et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: